C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2001
12/27/2001	WO2001098366A2 Enterokinase cleavage sequences and their use
12/27/2001	WO2001098361A2 Agonist anti-trk-c monoclonal antibodies
12/27/2001	WO2001098360A2 Gp354 nucleic acids and polypeptides
12/27/2001	WO2001098356A1 Low oxygen affinity mutant hemoglobins
12/27/2001	WO2001098354A2 Human receptors
12/27/2001	WO2001098353A2 Secreted proteins
12/27/2001	WO2001098351A2 G-protein coupled receptors
12/27/2001	WO2001098342A1 Novel compounds
12/27/2001	WO2001098341A1 Novel polypeptide and its dna
12/27/2001	WO2001098338A2 Fluorescent proteins
12/27/2001	WO2001098334A2 Streptococcus antigens
12/27/2001	WO2001098333A2 Modification of hepatitis b core antigen
12/27/2001	WO2001098332A2 Secreted redox proteins
12/27/2001	WO2001098324A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains
12/27/2001	WO2001098323A2 G-protein coupled receptors
12/27/2001	WO2001097846A1 Treatment of central nervous system diseases by antibodies against glatiramer acetate
12/27/2001	WO2001066243A3 Matrix reactor and a method for producing products in said reactor
12/27/2001	WO2001049711A3 Nucleic acids encoding (poly)peptides having chips activity
12/27/2001	WO2001046256A3 Vesicle trafficking proteins
12/27/2001	WO2001044467A3 Method for obtaining human cdc25 phosphatases and method for identifying human cdc25 phosphatase modulators
12/27/2001	WO2001038532A3 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
12/27/2001	WO2001038490A3 ISOLATION OF FIVE NOVEL GENES CODING FOR NEW Fc RECEPTORS-TYPE MELANOMA INVOLVED IN THE PATHOGENESIS OF LYMPHOMA/MELANOMA
12/27/2001	WO2001027258A3 High yield protein expression system and methods
12/27/2001	WO2001025456A3 Method for production of proteinaceous substances
12/27/2001	US20010056076 Treatment of acute lung injury and fibrosis with antagonists of alphavbeta6
12/27/2001	US20010055791 Methods for enhancing the production of interferon in cell culture
12/27/2001	US20010055789 Nucleotide sequences for use in the generation of amidated peptides
12/27/2001	US20010055758 Reagents and methods useful for detecting diseases of the prostate
12/27/2001	US20010055595 Detection and treatment of infections with immunoconjugates
12/27/2001	CA2805216A1 Antigenic polypeptides from staphylococcus
12/27/2001	CA2414228A1 Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof
12/27/2001	CA2414028A1 Low oxygen affinity mutant hemoglobins
12/27/2001	CA2414015A1 Human receptors
12/27/2001	CA2414010A1 Secreted redox proteins
12/27/2001	CA2414005A1 Novel compounds
12/27/2001	CA2413986A1 Gp354 nucleic acids and polypeptides
12/27/2001	CA2413870A1 Recombinant proteolytic tryptases, active site mutants thereof, and methods of making same
12/27/2001	CA2413612A1 Modified construct downstream of the initiation codon for recombinant protein overexpression
12/27/2001	CA2413468A1 Methods and means for regulation of gene expression
12/27/2001	CA2413454A1 A g-protein coupled receptor
12/27/2001	CA2413450A1 Streptococcus antigens
12/27/2001	CA2413324A1 Treatment of central nervous system diseases by antibodies against glatiramer acetate
12/27/2001	CA2412734A1 Renal regulatory elements and methods of use thereof
12/27/2001	CA2412484A1 G-protein coupled receptors
12/27/2001	CA2412110A1 Osteolevin gene polymorphisms
12/27/2001	CA2412053A1 Grain processing method and transgenic plants useful therein
12/27/2001	CA2411971A1 Proteases
12/27/2001	CA2411756A1 Mutation associated with epilepsy
12/27/2001	CA2410224A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains
12/27/2001	CA2409781A1 Phosphodiesterases
12/27/2001	CA2409778A1 Secreted proteins
12/27/2001	CA2409776A1 G-protein coupled receptors
12/27/2001	CA2408630A1 Novel enterokinase cleavage sequences
12/26/2001	CN1328605A Methods for making recombinant cells
12/26/2001	CN1328571A Human monoclonal antibodies to CTLA-4
12/26/2001	CN1328156A Process for preparing fusion protein used for glucose sensor
12/26/2001	CN1328061A Application of genetically engineered fish growth hormone in aquatic product culture
12/26/2001	CA2350043A1 Novel melanocortin -4 receptor sequences and screening assays to identify compounds useful in regulating animal appetite and metabolic rate
12/25/2001	US6333403 Nucleotide sequences coding polypeptide associated with tumors; for use in diagnosis and treatment of tumors
12/25/2001	US6333402 For therapy and diagnosis
12/25/2001	US6333400 Amino acid transporters and sues
12/25/2001	US6333397 Hybridoma cell culture; for use in generation of preferential immunoglobulin which binds preferential muscle protein; for use in diagnosis of heart defects
12/25/2001	US6333396 Genetically engineered binding polypeptide; for use in cancer diagnosis and therapy; for use in gene therapy
12/25/2001	US6333310 NGF variants
12/25/2001	US6333309 Having anti-tumor activity, a leukemia cell differentiation inducing activity, a cellular immunology enhancing activity, a vascular endothelial cell growth stimulating activity and a hepatocyte growth stimulating activity
12/25/2001	US6333305 For therapy of fungal infections
12/25/2001	US6333175 Yield when disulfide-bonded proteins are secreted
12/25/2001	US6333174 Transforming a bacterial inoculant with a replicable plasmid having a double stranded dna, a tryptophan promoter, ribosome binding site, a translation start signal with structural genes coding a leade, culture with tryptophan
12/25/2001	US6333168 Cloning, expression and uses of dorsalin-1
12/25/2001	US6333161 Assaying a test ligands ability to bind a central nervous system receptor by incubation the ligand with mutant cells that produce a kainate-binding excitatory amino acid receptor and determining the extent of binding
12/25/2001	US6333035 Administering monoclonal antibody against a human t-cell leukemia virus-derived transcription activating factor p40tax-induced cell membrane glycoprotein of 34 kda (gp34) in an amount effective for treating rheumatoid arthritis
12/25/2001	CA2186775C Ribosome fraction and composition containing the same
12/25/2001	CA2094027C Osteogenic peptides
12/20/2001	WO2001096875A2 Hcv antigen/antibody combination assay
12/20/2001	WO2001096870A2 Immunoassays for anti-hcv antibodies
12/20/2001	WO2001096577A1 Production of secreted polypeptides
12/20/2001	WO2001096574A1 Novel enzyme gene and its expression product
12/20/2001	WO2001096566A1 Gasc1 gene
12/20/2001	WO2001096565A2 Binding agents: chimeric ligand/receptor proteins
12/20/2001	WO2001096563A1 Scramblase 2
12/20/2001	WO2001096562A1 Thyrotropin-releasing hormone receptor-like gpcr (gprfwki)
12/20/2001	WO2001096558A1 Polyfunctional base sequence and artificial gene containing the same
12/20/2001	WO2001096557A2 A human homologue of the dbf4/ask1 protein, nucleic acids, and methods related to the same
12/20/2001	WO2001096552A1 Sodium channels scn1a and scn3a
12/20/2001	WO2001096547A2 Human kinases
12/20/2001	WO2001096546A2 Protein phosphatases
12/20/2001	WO2001096400A2 52871, a novel human g protein coupled receptor and uses thereof
12/20/2001	WO2001096393A2 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
12/20/2001	WO2001096377A2 Vaccine for congenital tremors in pigs
12/20/2001	WO2001096376A2 Pro-apoptotic fragments of the dengue virus envelope glycoproteins
12/20/2001	WO2001096368A2 Use of coiled-coil structural scaffold to generate structure-specific peptides
12/20/2001	WO2001064751A3 High potency recombinant antibodies and method for producing them
12/20/2001	WO2001059100A3 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization
12/20/2001	WO2001055306A3 Nucleic acids, proteins, and antibodies
12/20/2001	WO2001046390A3 Method of inactivating microorganisms
12/20/2001	WO2001029207A8 Antiuracil monoclonal antibody
12/20/2001	WO2001023592A3 Methods for making recombinant proteins using apoptosis inhibitors
12/20/2001	WO2000068387A3 Nucleic acids and proteins with interferon-beta activity
12/20/2001	WO2000058358A9 49 human secreted proteins
12/20/2001	WO2000008133A9 NOVEL G PROTEIN-COUPLED RECEPTOR cDNA SEQUENCE

1 ... 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 ... 1125